MedPAC > Our Work > Delivery System Reforms > MedPAC comment on CMS’s proposed rule on requiring drug pricing transparency MedPAC comment on CMS’s proposed rule on requiring drug pricing transparency Nov 28, 2018 / Comment Letters Download Full Comment Letter